Physicians at Baltimore VA Say They Prefer Filmless Radiology System

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 7
Volume 6
Issue 7

BOSTON--A medical center that has gone to a completely filmless radiology department got a show of support from the medical and surgical staff.

BOSTON--A medical center that has gone to a completely filmless radiologydepartment got a show of support from the medical and surgical staff.

In a survey conducted after the system had been in use for three years,more than three fourths of respondents (78%) at the Baltimore VA MedicalCenter said they strongly preferred the filmless system over conventionalx-ray film. Only 7% said they still preferred film, and 15% had no preference.

The Picture Archival and Communications System (PACS) in operation atthe Baltimore VA is a digital medical imaging network that can be usedby the entire hospital staff for storing and retrieving radiologic images.Overall, PACS results in increased efficiency, improved availability ofimages, and better use of physicians' time, lead investigator Zenon Protopapas,MD, said at the American Roentgen Ray Society annual meeting.

Dr. Protopapas, who was on the radiology staff at the VA hospital whenthe study was conducted, is now affiliated with the Hospital of St. Raphael,New Haven, Conn.

Questionnaires were mailed to 280 attending physicians, residents, andphysician assistants, most of whom worked both at the filmless BaltimoreVA and the film-based University of Maryland Hospital. The response ratewas 40%.

The feeling that the filmless system contributes to a more efficientuse of clinical time was almost universal, with 90% of respondents in agreement.Close to 80% of those surveyed said the filmless system actually savedtime--on average, 36 minutes per day per physician. The respondents reportedaccessing the system a median of three to five times a day.

More than half (57%) said that PACS use did not change the frequencywith which they consult with radiologists; 35% reported a decreased frequency,and 8% reported an increase.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The FDA approval of tarlatamab in SCLC has received much press attention, according to Daniel R. Carrizosa, MD, MS.
These new guidelines aim to alleviate some of the problems caused by patients with peritoneal metastases being diagnosed with the disease in late stages.
A combined cohort composed of patients from the TROPION-Lung01 and TROPION-Lung-05 trials showed a survival advantage with dato-DXd vs docetaxel.
The National ICE-T Conference may inspire future collaboration between community and academic oncologists in the management of different cancers.
4 experts in this video
2 experts are featured in this series.
4 experts in this video
5 experts are featured in this series
Related Content